Global health & medicine
Jun 30, 2026
This article examines the ethical governance of artificial intelligence (AI) use in drug development through joint principles of good AI practice issued by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). It argues...
Global health & medicine
Jun 30, 2026
Medical Adaptive Machine Learning Systems (MAMLS) that continuously update their models using clinical data blur the conventional boundary between therapy and research, prompting the argument that their use should be classified as research and govern...
Global health & medicine
Jun 30, 2026
Artificial intelligence (AI) has advanced rapidly across clinical domains, generating both a growing evidence base and dedicated regulatory frameworks for AI-based software as a medical device (SaMD). This review provides a comprehensive assessment o...
Global health & medicine
Jun 30, 2026
Unplanned removal of life-sustaining tubes in intensive care units (ICUs) poses serious risks, yet existing monitoring methods relying on physical restraints have ethical and clinical drawbacks. Here we applied artificial intelligence (AI)-based pose...
Global health & medicine
Jun 30, 2026
The objective of this study was to develop an automated deep learning-based method for the assessment of shoulder balance in adolescent idiopathic scoliosis (AIS) patients using X-ray images in order to provide a reliable and efficient alternative to...
Global health & medicine
Jun 30, 2026
Artificial intelligence (AI) in dermatology has moved beyond the early paradigm of single-image classification. Dermatological diagnosis is achieved based on morphology, distribution, symptoms, tactile findings, temporal evolution, patient history, h...
Global health & medicine
Jun 30, 2026
Loneliness and social isolation are important psychosocial concerns in dementia care, but they are difficult to address through pharmacological treatment or episodic social activities alone. Companion technologies, including socially assistive robots...
Global health & medicine
Jun 30, 2026
The rapid expansion of artificial intelligence (AI) in healthcare has led to increasing adoption of AI-based software as a medical device (SaMD). This paper reviews the current regulatory and approval framework for AI-based SaMD in Japan and discusse...
Global health & medicine
Jun 30, 2026
The Pharmaceuticals and Medical Devices Agency (PMDA) continues to face increasing operational demands stemming from growing regulatory complexity, expanding data volumes, and evolving scientific and societal expectations. In this context, the approp...
Global health & medicine
Jun 30, 2026
Primary liver cancer presents substantial management challenges across the surgical trajectory, including high recurrence rates, prolonged rehabilitation, and fragmented post-discharge care. This correspondence presents a multidisciplinary physician-...